Email: cspc@cspc.cn
News
News Center
Sep. 12
2025
VOLUNTARY ANNOUNCEMENT - SYH2066 TABLETS OBTAIN CLINICAL TRIAL APPROVAL IN CHINA
Sep. 11
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR KN026 (ANBENITAMAB INJECTION) ACCEPTED BY THE NMPA
Aug. 22
VOLUNTARY ANNOUNCEMENT - SYS6036 INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Aug. 19
VOLUNTARY ANNOUNCEMENT - DUPILUMAB INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Aug. 05
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTANCE OF APPLICATION FOR MARKETING APPROVAL OF SEMAGLUTIDE INJECTION
Jul. 30
VOLUNTARY ANNOUNCEMENT - ENTERING INTO EXCLUSIVE LICENSE AGREEMENT FOR SYH2086 WITH MADRIGAL
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us
